111 results on '"Berghoff M"'
Search Results
2. Crystal-melt interface mobility in bcc Fe: Linking molecular dynamics to phase-field and phase-field crystal modeling
3. Perceptions on the value of bodily functions in multiple sclerosis
4. On the homology of independence complexes
5. Perceptions on the value of bodily functions in multiple sclerosis
6. Feynman amplitudes on moduli spaces of graphs
7. A Case of Natalizumab-associated Progressive Multifocal Leukoencephalopathy—Role for Advanced MRI?
8. Prediction of heat conduction in open-cell foams via the diffuse interface representation of the phase-field method
9. Concentrations and regulation of adipokines resistin and progranulin in human cerebrospinal fluid
10. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
11. Scale-bridging phase-field simulations of microstructure responses on nucleation in metals and colloids
12. Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial
13. A Case of Natalizumab-associated Progressive Multifocal Leukoencephalopathy—Role for Advanced MRI?
14. Description of hard-sphere crystals and crystal-fluid interfaces: A comparison between density functional approaches and a phase-field crystal model
15. Gene Silencing of MK2 in Hard-to-Transfect Human U937 Cells
16. 7 Tesla MRI demonstrates vascular pathology in Baló’s concentric sclerosis
17. MK2-Deficiency Fails To Protect Mice from Experimental Autoimmune Encephalomyelitis (P05.114)
18. mRNA-expression patterns of Fas and its signalling cascade in Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE)
19. Bedeutung des Chemokinrezeptors CCR2 in Tiermodellen hereditärer Neuropathien
20. Bedeutung des Chemokinrezeptors CCR2 in Tiermodellen hereditärer Neuropathien
21. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy
22. Niedrigflußnarkosen mit Desfluran
23. POSITIONAL CLONING OF THE CMT2B2 GENE AND ITS IMPLICATIONS FOR CMT1A
24. MICE HETEROZYGOUSLY DEFICIENT FOR THE MYELIN COMPONENT P0 SHOW INCREASED ERK-PHOSPHORYLATION AND MCP-1 EXPRESSION AT INITIAL STAGES OF PRIMARILY GENETICALLY-MEDIATED DEMYELINATION
25. M-CSF ACTIVATES PATHOGENIC RESIDENT AND INFILTRATING MACROPHAGES AND MEDIATES MYELIN PHAGOCYTOSIS IN A MOUSE MODEL FOR AN INHERITED DEMYELINATING NEUROPATHY
26. A CHEMICAL AND PHYSICAL ASSESSMENT OF SMALL NERVE FIBER FUNCTION IN DIABETES MELLITUS
27. Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1
28. Ablation of oligodendroglial FGFR1 results in enhanced Trk B expression in mice
29. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
30. Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
31. The Polynucleotide Kinase 3-Phosphatase Gene is not Responsible for Autosomal Recessive Charcot-Marie-Tooth Disease type 2 in Chromosome 19q13.3
32. Magnetic resonance imaging outcomes from a phase III trial of teriflunomide
33. Schulungsprogramm zu Diagnose, Prognose und Frühtherapie für Menschen mit früher oder möglicher Multiple Sklerose – eine multizentrische randomisiert-kontrollierte Studie (ISRCTN12440282)
34. S^1-equivariant Morse cohomology
35. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
36. Characterization of the Valsalva maneuver using wavelet transform
37. Characterization of the Valsalva maneuver using wavelet transform.
38. Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis.
39. Abnormal vasoreaction to arousal stimuli--an early sign of diabetic sympathetic neuropathy demonstrated by laser Doppler flowmetry.
40. 7 Tesla MRI demonstrates vascular pathology in Baló’s concentric sclerosis.
41. Grid technology in tissue-based diagnosis: fundamentals and potential developments
42. The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis.
43. Multiscale Modeling of Spheroid Tumors: Effect of Nutrient Availability on Tumor Evolution.
44. Is There Reduced Hemodynamic Brain Activation in Multiple Sclerosis Even with Undisturbed Cognition?
45. Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis.
46. Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic.
47. Correction to: Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two‑step process.
48. Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process.
49. Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG 35-55 -Induced EAE.
50. [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.